ABIMAEL RIVERA CRUZ

Allopathic & Osteopathic Physicians|Dermatology ARECIBO, PR NPI 1588839765

General Payments — all program years on this page

$3,004.60

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 104
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $603.50 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $504.5019
Education $99.001

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ABBVIE INC. $312.1613
GENZYME CORPORATION $149.174
Janssen Biotech, Inc. $99.001
Eli Lilly Export S.A. Puerto Rico Branch $23.171
Amgen Inc. $20.001

By program year

Program yearAmountRecords
2018 $84.814
2019 $652.2817
2020 $392.369
2021 $200.0514
2022 $774.3530
2023 $297.2510
2024 $603.5020

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078614466 Janssen Biotech, Inc. $99.00 04/30/2024 Education Undisputed 01/23/2026 View at CMS
1105953078 ABBVIE INC. $22.93 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105953080 ABBVIE INC. $4.88 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105953082 ABBVIE INC. $8.40 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105953084 ABBVIE INC. $23.19 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105953086 ABBVIE INC. $1.14 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105953088 ABBVIE INC. $5.29 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105953090 ABBVIE INC. $22.93 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105953092 ABBVIE INC. $23.18 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105953094 ABBVIE INC. $5.79 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105953096 ABBVIE INC. $23.19 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105953098 ABBVIE INC. $124.95 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105953100 ABBVIE INC. $23.70 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105953102 ABBVIE INC. $22.59 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111689062 Amgen Inc. $20.00 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135994690 Eli Lilly Export S.A. Puerto Rico Branch $23.17 07/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139814719 GENZYME CORPORATION $8.35 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139814733 GENZYME CORPORATION $14.63 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139814783 GENZYME CORPORATION $118.71 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139814785 GENZYME CORPORATION $7.48 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.